MANFREDI, Andreina Teresa
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 11.532
EU - Europa 9.656
AS - Asia 1.647
SA - Sud America 97
OC - Oceania 75
AF - Africa 60
Continente sconosciuto - Info sul continente non disponibili 17
Totale 23.084
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 11.353
IT - Italia 5.061
GB - Regno Unito 1.899
SE - Svezia 853
CN - Cina 575
DE - Germania 438
UA - Ucraina 331
FR - Francia 312
TR - Turchia 286
HK - Hong Kong 276
FI - Finlandia 238
BG - Bulgaria 153
JP - Giappone 119
CA - Canada 85
IE - Irlanda 83
IN - India 83
MX - Messico 73
AU - Australia 68
ID - Indonesia 65
RU - Federazione Russa 44
VN - Vietnam 39
PL - Polonia 37
PK - Pakistan 36
SG - Singapore 33
AR - Argentina 32
NL - Olanda 32
KR - Corea 29
TN - Tunisia 28
LT - Lituania 27
CH - Svizzera 25
IR - Iran 24
BE - Belgio 23
MY - Malesia 23
BR - Brasile 22
ES - Italia 19
BZ - Belize 18
EU - Europa 16
RO - Romania 16
HU - Ungheria 14
SA - Arabia Saudita 13
CL - Cile 12
CO - Colombia 11
PE - Perù 11
EG - Egitto 10
TW - Taiwan 10
AT - Austria 9
PH - Filippine 9
NZ - Nuova Zelanda 7
PT - Portogallo 7
IL - Israele 6
JO - Giordania 6
LU - Lussemburgo 6
DK - Danimarca 5
DZ - Algeria 5
EC - Ecuador 5
KE - Kenya 5
ZA - Sudafrica 5
GR - Grecia 4
IQ - Iraq 4
RS - Serbia 4
CZ - Repubblica Ceca 3
MA - Marocco 3
NO - Norvegia 3
BD - Bangladesh 2
BO - Bolivia 2
GT - Guatemala 2
LB - Libano 2
LV - Lettonia 2
MD - Moldavia 2
NP - Nepal 2
SI - Slovenia 2
VE - Venezuela 2
A1 - Anonimo 1
AE - Emirati Arabi Uniti 1
AL - Albania 1
AZ - Azerbaigian 1
CY - Cipro 1
ET - Etiopia 1
GH - Ghana 1
HN - Honduras 1
HR - Croazia 1
KZ - Kazakistan 1
MM - Myanmar 1
MZ - Mozambico 1
SK - Slovacchia (Repubblica Slovacca) 1
UG - Uganda 1
VA - Santa Sede (Città del Vaticano) 1
Totale 23.084
Salva come PNG Salva come JPEG
Città #
Fairfield 1.722
Southend 1.515
Woodbridge 941
Chandler 917
Ashburn 861
Houston 735
Wilmington 584
Seattle 579
Jacksonville 564
Ann Arbor 531
Cambridge 530
Nyköping 513
Dearborn 387
Milan 361
Rome 310
Hong Kong 259
Modena 214
San Diego 179
Beijing 175
Izmir 175
New York 158
Helsinki 155
Sofia 149
Princeton 147
Redwood City 132
Eugene 113
London 86
Palermo 81
Bremen 77
Florence 77
Bari 74
Bologna 71
Falls Church 71
Catania 66
Jakarta 60
Naples 58
Dublin 52
Los Angeles 52
Boardman 48
Des Moines 47
Perth 46
Shanghai 46
Tokyo 46
Padova 43
Genoa 42
San Jose 40
Verona 40
Turin 39
Frankfurt am Main 31
Cagliari 30
Dong Ket 30
Norwalk 26
Salerno 26
Guangzhou 25
Parma 25
Messina 24
Ottawa 24
Chicago 23
Singapore 23
Trento 23
Brescia 22
Reggio Emilia 21
Livorno 20
Napoli 19
Belize City 18
Pisa 18
Reggio Nell'emilia 18
Torino 18
Toronto 18
Hounslow 17
Nanjing 17
Atlanta 16
Caserta 16
Council Bluffs 16
Mountain View 16
Pescara 16
Bergamo 15
Mumbai 15
Brussels 14
Dallas 14
Jinan 14
Kunming 14
Legnano 14
Monza 14
Phoenix 14
Treviso 14
Trieste 14
Venice 14
Buenos Aires 13
Hefei 13
Puebla City 13
Forlì 12
Hangzhou 12
Kilburn 12
Mexico City 12
Perugia 12
Reggio Calabria 12
Bogotá 11
Chiswick 11
Hamilton 11
Totale 15.078
Salva come PNG Salva come JPEG
Nome #
INTERSTIZIOPATIA POLMONARE NON CLASSIFICABILE O SECONDARIA A CONNETTIVITE INDIFFERENZIATA. IMPORTANZA E DIFFICOLTÀ DI UNA DIAGNOSI DIFFERENZIALE. 2.748
TIPIZZAZIONE CLINICA DELLA SINDROME ANTISINTETASICA: CONFRONTO TRA PAZIENTI ANTI JO-1 POSITIVI E NEGATIVI 1.011
Epidemiology and management of interstitial lung disease in ANCA-associated vasculitis 824
ALTERAZIONI CAPILLAROSCOPICHE IN CORSO DI DERMATOMIOSITE E SCLEROSI SISTEMICA; VERSO L’INDIVIDUAZIONE DI PATTERN SPECIFICI 555
La capillaroscopia in reumatologia. Lesioni elementari e metodi di scoring 333
Evoluzione dello CSURI (Capillaroscopic Skin Ulcer Risk Index) in pazienti affetti da sclerosi sistemica in terapia con antiendotelina-1 e prostanoidi 265
Diagnostic accuracy of a velcro sound detector (VECTOR) for interstitial lung disease in rheumatoid arthritis patients: The InSPIRAtE validation study (INterStitial pneumonia in rheumatoid ArThritis with an electronic device) 257
Analysis of pulmonary sounds for the diagnosis of interstitial lung diseases secondary to rheumatoid arthritis 245
Recommendations for the management of pulmonary fungal infections in patients with rheumatoid arthritis 241
Radiologic classification of usual interstitial pneumonia in rheumatoid arthritis-related interstitial lung disease: correlations with clinical, serological and demographic features of disease 239
Oxycodone in the Long-Term Treatment of Chronic Pain Related to Scleroderma Skin Ulcers. 235
Efficacia di terapia con immunoassorbimento con proteina A dello stafilococco e talidomide in un caso di dermatomiosite refrattaria. 223
Current treatment of hepatitis C-associated rheumatic diseases. 222
Cryoglobulinemic vasculitis and skin ulcers. Our therapeutic strategy and review of the literature 220
Predictive value of isolated DLCO reduction in systemic sclerosis patients without cardio-pulmonary involvement at baseline 219
Gynaecological Screening for Cervical and Vulvar Malignancies in a Cohort of Systemic Sclerosis Patients: Our Experience and Review of the Literature 206
Combination Therapy with Nintedanib and Sarilumab for the Management of Rheumatoid Arthritis Related Interstitial Lung Disease 206
Carotidynia Possibly due to Localized Vasculitis in a Patient with Latent Mycobacterium tuberculosis Infection. 203
NEW PERSPECTIVES IN DIAGNOSIS OF INTERSTITIAL LUNG DISEASE RELATED TO RHEUMATOID ARTHRITIS. VALIDATION STUDY OF AN ELECTRONIC STETHOSCOPE AND AD HOC SOFTWARE FOR DETECTION OF PULMONARY CRACKLES 202
Serum 25-OH vitamin D levels in systemic sclerosis: analysis of 140 patients and review of the literature 199
Aortic pulse wave velocity measurement in systemic sclerosis patients. 195
Nailfold capillaroscopic changes in dermatomyositis and polymyositis 192
Cardiac Involvement in Systemic Vasculitis 189
Capillaroscopic skin ulcer risk index: a new prognostic tool for digital skin ulcer development in systemic sclerosis patients. 185
Lung cancer in scleroderma: results from an Italian rheumatologic center and review of the literature. 185
Prevalence and evolution of scleroderma pattern at nailfold videocapillaroscopy in systemic sclerosis patients: Clinical and prognostic implications 178
Systemic sclerosis evolution of disease pathomorphosis and survival. Our experience on Italian patients' population and review of the literature 176
Interstitial pneumonia with autoimmune features and undifferentiated connective tissue disease: Our interdisciplinary rheumatology-pneumology experience, and review of the literature 175
Acute exacerbation of interstitial lung diseases secondary to systemic rheumatic diseases: A prospective study and review of the literature 175
Timing of onset affects arthritis presentation pattern in antisyntethase syndrome 174
Effect of treatment with iloprost with or without bosentan on nailfold videocapillaroscopic alterations in patients with systemic sclerosis 174
Bronchoalveolar lavage and response to cyclophosphamide in scleroderma alveolitis. 173
Antiendothelial cell antibodies induce apoptosis of bone marrow endothelial progenitors in systemic sclerosis. 169
Systemic sclerosis and cryoglobulinemia: our experience with overlapping syndrome of scleroderma and severe cryoglobulinemic vasculitis and review of the literature. 169
Tocilizumab therapy in rheumatoid arthritis with interstitial lung disease: a multicenter retrospective study 169
Nailfold Videocapillaroscopy Alterations in Dermatomyositis and Systemic Sclerosis: Toward Identification of a Specific Pattern 168
Prevalence and characterization of non-sicca onset primary Sjögren syndrome with interstitial lung involvement 167
Therapeutic options after treatment failure in rheumatoid arthritis or spondyloarthritides 166
Italian consensus Guidelines for the management of hepatitis B virus infections in patients with rheumatoid arthritis 162
Nailfold Capillaroscopy Characteristics of Antisynthetase Syndrome and Possible Clinical Associations: Results of a Multicenter International Study 161
Scleroderma digital ulcers complicated by infection with fecal pathogens. 158
Measuring microangiopathy abnormalities in systemic sclerosis patients: the role of capillaroscopy-based scoring models 157
Radiological thymus alterations in systemic sclerosis: our experience and a review of the literature. 156
D-penicillamine in the treatment of eosinophilic fasciitis: case reports and review of the literature. 155
Prediction risk chart for scleroderma digital ulcers: A composite predictive model based on capillaroscopic, demographic and clinico-serological parameters 155
HRCT Patterns Of Usual Interstitial Pneumonia In Rheumatoid Lung 150
Capillaroscopic Skin Ulcers Risk Index (CSURI) calculated with different videocapillaroscopy devices: how its predictive values change 148
Neurologic Complications Associated with Sjögren's Disease: Case Reports and Modern Pathogenic Dilemma 148
The performance of the GAP model in patients with rheumatoid arthritis associated interstitial lung disease 148
Scleroderma Digital Ulcers Complicated by Infection with Fecal Pathogens. 146
Correlation of a quantitative videocapillaroscopic score with the development of digital skin ulcers in scleroderma patients 146
Thyroid involvement in hepatitis C - associated mixed cryoglobulinemia 146
Procedural pain management in the treatment of scleroderma digital ulcers 145
Factors Predicting Early Failure of Etanercept in Rheumatoid Arthritis: An Analysis From the Gruppo Italiano di Studio sulla Early Arthritis (Italian Group for the Study of Early Arthritis) Registry 145
CORRELATION OF A QUANTITATIVE VIDEOCAPILLAROSCOPIC SCORE WITH THE DEVELOPMENT OF DIGITAL SKIN ULCERS IN SCLERODERMA PATIENTS 144
PATIENTS WITH MIXED CRYOGLOBULINEMIA AND HCV INFECTION, IN PRESENCE OR ABSENCE OF AUTOIMMUNE THYROIDITIS, HAVE HIGH SERUM LEVELS OF (CXC MOTIF) LIGAND (CXCL)9 AND CXCL11 CHEMOKINES 144
UNCLASSIFIABLE INTERSTITIAL LUNG DISEASE OR UNDIFFERENTIATED CONNECTIVE TISSUE DISEASE? A CHALLENGING DIFFERENTIAL DIAGNOSIS 142
Osteomyelitis complicating scleroderma digital ulcers. 141
Tocilizumab for the treatment of patients with rheumatoid arthritis and interstitial lung diseases: a case series 141
Nailfold videocapillaroscopy in antisynthetase syndrome 140
Platelet gel in the treatment of severe scleroderma skin ulcers. 139
AB1157 VALIDATION OF VECTOR (VELCRO CRACKLES DETECTOR) FOR THE DIAGNOSIS OF INTERSTITIAL LUNG DISEASE IN PATIENTS WITH CONNECTIVE TISSUE DISEASES 139
Validation study of predictive value of capillaroscopic skin ulcer risk index (CSURI) in scleroderma patients treated with bosentan 138
Circulating CXCL11 and CXCL10 are increased in hepatitis C-associated cryoglobulinemia in the presence of autoimmune thyroiditis. 133
Recombinant human erythropoietin stimulates vasculogenesis and wound healing in a patient with systemic sclerosis complicated by severe skin ulcers. 133
Cardiovascular risk and prostanoids in systemic sclerosis 131
COST ANALYSIS RELATED TO SUBCUTANEOUS IMMUNOGLOBULINS IN PATIENTS WITH INFLAMMATORY MYOPATHIES AND IMMUNE-MEDIATED CHRONIC NEUROPATHIES. RESULTS OF AN OPEN LABEL STUDY 131
Italian consensus recommendations for the management of hepatitis C infection in patients with rheumatoid arthritis 131
Safety of Abatacept in Italian Patients with Rheumatoid Arthritis and Interstitial Lung Disease: A Multicenter Retrospective Study 130
Staphylococcus protein A-based extracorporeal immunoadsorption and thalidomide in the treatment of skin manifestation of dermatomyositis: a case report. 129
Trattamento con IgIV ad alte dosi in un caso di dermatomiosite con grave disfagia refrattaria alle terapie standard. 129
RHEUMATOID ARTHRITIS RELATED INTERSTITIAL LUNG DISEASE. RADIOLOGICAL PATTERNS AND CORRELATIONS WITH CLINICAL, SEROLOGICAL AND DEMOGRAPHIC FEATURES OF DISEASE 129
Interstitial pneumonia with autoimmune features: A single center prospective follow-up study 129
Trattamento della fascite eosinofila con D-penicillamina: descrizione di 3 casi. 128
Predictive role of capillaroscopic skin ulcer risk index in systematic sclerosis: a multicentre validation study 127
Therapeutic Options for the Treatment of Interstitial Lung Disease Related to Connective Tissue Diseases. A Narrative Review 127
Interstitial lung disease is associated to infections of lower respiratory tract in immunocompromised rheumatoid arthritis patients 125
Efficacy and safety of mycophenolate mofetil in the treatment of rheumatic disease-related interstitial lung disease: a narrative review 125
PAP-TEST FEATURES IN A COHORT OF SYSTEMIC SCLEROSIS PATIENTS 124
CXCL10 (alpha) and CCL2 (beta) chemokines in systemic sclerosis--a longitudinal study. 124
CAPILLAROSCOPIC SKIN ULCER RISK INDEX (CSURI) IN SYSTEMIC SCLEROSIS: RESULTS FROM AN ITALIAN MULTICENTER VALIDATION STUDY 123
INTERSTITIAL LUNG DISEASE IS ASSOCIATED TO INFECTIONS OF LOWER RESPIRATORY TRACT IN IMMUNOCOMPROMISED RHEUMATOID ARTHRITIS PATIENTS 122
Modulatory effects of peroxisome proliferator-activated receptor-γ on CXCR3 chemokines 119
High circulating chemokines (C-X-C motif) ligand 9, and (C-X-C motif) ligand 11, in hepatitis C-associated cryoglobulinemia. 118
Mixed cryoglobulinemia syndrome: where are we going to? 117
AB0472 PRIMARY SJOGREN SYNDROME ASSOCIATED INTERSTITIAL LUNG DISEASE: FEATURES, TREATMENT AND OUTCOME OF A MONOCENTRIC COHORT 116
AB0624 SAFETY OF RITUXIMAB BIOSIMILAR FOR THE TREATMENT OF CRYOGLOBULINEMIC VASCULITIS 114
Efficacy and safety of rituximab in the treatment of connective tissue disease-related interstitial lung disease 113
Chemokine (CXC motif) ligand 9 serum levels in mixed cryoglobulinemia are associated with circulating levels of IFN-γ and TNF-α 112
Scleroderma skin ulcers definition, classification and treatment strategies our experience and review of the literature 111
Predictive Value of DLCO Reduction in Scleroderma Patients Without Cardio-Pulmonary Involvement at Baseline 110
Trattamento del dolore in reumatologia con oppioidi: nostra esperienza con ossicodone in pazienti con ulcere cutanee vasculitiche. 109
SEVERE VITAMIN D DEFICIENCY IN SYSTEMIC SCLEROSIS 106
DIGITAL NECROSIS IN SYSTEMIC SCLEROSIS NOT ONLY A MICROVASCULAR DISEASE: A CASE REPORT 106
Influence of Antisynthetase Antibodies Specificities on Antisynthetase Syndrome Clinical Spectrum Time Course 106
Pirfenidone for the treatment of interstitial lung disease associated to rheumatoid arthritis: a new scenario is coming? 105
NAILFOLD CAPILLAROSCOPIC ALTERATIONS IN DERMATOMYOSITIS AND POLYMYOSITIS 102
Treatment of Rheumatoid Arthritis-Associated Interstitial Lung Disease: Lights and Shadows 101
Prise en charge de l'infection par le virus de l'hépatite B chez les patients atteints de polyarthrite rhumatoïde: conférence de consensus italienne [Italian consensus guidelines for the management of hepatitis B virus infections in patients with rheumatoid arthritis] 100
Antifibrotic drugs in connective tissue disease-related interstitial lung disease (CTD-ILD): from mechanistic insights to therapeutic applications 100
Totale 20.121
Salva come PNG Salva come JPEG
Categoria #
all - tutte 90.549
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 90.549
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/2019620 0 0 0 0 0 0 0 0 0 0 0 620
2019/20203.894 360 163 131 200 340 630 540 503 430 201 217 179
2020/20214.266 333 128 297 365 448 404 370 550 297 458 306 310
2021/20223.473 193 277 265 268 170 287 182 196 389 316 512 418
2022/20234.459 457 336 271 316 439 532 264 438 536 204 391 275
2023/20244.089 221 274 279 454 574 346 355 548 151 240 342 305
Totale 23.513